Evaluating the impact of prevention of mother-to-child transmission of HIV in Malawi through immunization clinic-based surveillance MA Sinunu, EJ Schouten, N Wadonda-Kabondo, E Kajawo, M Eliya, ... PloS one 9 (6), e100741, 2014 | 40 | 2014 |
Use of laboratory test results in patient management by clinicians in Malawi K Moyo, C Porter, M Kabue, B Chilima, L Zungu, R Mwenda, A Sarr African journal of laboratory medicine 4 (1), 1-8, 2015 | 23 | 2015 |
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program N Wadonda-Kabondo, D Bennett, JJ van Oosterhout, K Moyo, ... Clinical infectious diseases 54 (suppl_4), S362-S368, 2012 | 23 | 2012 |
A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi N Wadonda-Kabondo, BL Hedt, JJ van Oosterhout, K Moyo, ... Clinical infectious diseases 54 (suppl_4), S355-S361, 2012 | 23 | 2012 |
Prevalence of Transmitted HIV Drug Resistance Among Newly Diagnosed Antiretroviral Therapy–Naive Pregnant Women in Lilongwe and Blantyre, Malawi N Wadonda-Kabondo, R Banda, K Moyo, M M’bang’ombe, M Chiwaula, ... Clinical infectious diseases 54 (suppl_4), S324-S327, 2012 | 13 | 2012 |
Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy Z Zhou, K Tang, G Zhang, N Wadonda-Kabondo, K Moyo, LA Rowe, ... African Journal of Laboratory Medicine 7 (1), 1-9, 2018 | 5 | 2018 |
Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy. ZZY Zhou ZhiYong, K Tang, ZGQ Zhang GuoQing, N Wadonda-Kabondo, ... | | 2018 |
Prevalence of HIV drug resistance before treatment initiation and at 12 months after treatment initiation in four sites in the Malawi ART programme N Wadonda, K Moyo, JJ van Oosterhout, J Aberle-Grasse, T Warne, ... ANTIVIRAL THERAPY 16 (4), A131-A131, 2011 | | 2011 |